Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US7731986 | PROVENSIS | Therapeutic foam |
Nov, 2024
(1 year, 5 months from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6846412 | PROVENSIS | Combination filter assembly |
Jul, 2022
(10 months ago) | |
US8122917 | PROVENSIS | Apparatus and method for dispensing foam |
Sep, 2024
(1 year, 3 months from now) | |
US7814943 | PROVENSIS | Apparatus and method for dispensing foam |
Nov, 2027
(4 years from now) | |
US9480652 | PROVENSIS | Aerosol valve |
May, 2032
(8 years from now) |
Market Authorisation Date: 25 November, 2013
Treatment: A method of generating an injectable foam of controlled density and bubble size; A method of intravenous injection using ultrasound guidance, administered via a single cannula into the lumen of the ta...
Dosage: SOLUTION;INTRAVENOUS
19
United States
9
United Kingdom
7
European Union
6
Japan
6
Germany
5
Australia
5
Korea, Republic of
5
Canada
5
Poland
5
China
4
Denmark
4
Spain
4
Austria
4
Cyprus
4
Portugal
4
Russia
4
Slovenia
2
Brazil
1
Ecuador
1
EA
1
India
1
Israel
1
OA
1
New Zealand
1
Czech Republic
1
Morocco
1
Norway
1
Hong Kong
1
Mexico
1
South Africa
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic